Zacks Small Cap Weighs in on SeaStar Medical FY2025 Earnings

SeaStar Medical Holding Corporation (NASDAQ:ICU) – Investment analysts at Zacks Small Cap issued their FY2025 EPS estimates for shares of SeaStar Medical in a report issued on Tuesday, January 13th. Zacks Small Cap analyst D. Bautz anticipates that the company will earn ($5.95) per share for the year. Zacks Small Cap also issued estimates for SeaStar Medical’s Q4 2025 earnings at ($0.97) EPS, FY2026 earnings at ($2.11) EPS and FY2027 earnings at ($1.63) EPS.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($1.30) EPS for the quarter, topping the consensus estimate of ($1.50) by $0.20. SeaStar Medical had a negative net margin of 1,551.08% and a negative return on equity of 414.50%. The firm had revenue of $0.18 million during the quarter, compared to analyst estimates of $0.25 million.

A number of other research firms also recently commented on ICU. Wall Street Zen upgraded SeaStar Medical to a “hold” rating in a report on Saturday, January 10th. Weiss Ratings restated a “sell (e+)” rating on shares of SeaStar Medical in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

SeaStar Medical Trading Down 2.8%

Shares of ICU opened at $2.79 on Thursday. SeaStar Medical has a twelve month low of $2.20 and a twelve month high of $30.70. The firm has a market capitalization of $10.04 million, a P/E ratio of -0.17 and a beta of -1.00. The stock’s fifty day simple moving average is $3.14 and its 200 day simple moving average is $5.77.

Hedge Funds Weigh In On SeaStar Medical

Hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd increased its position in SeaStar Medical by 395.4% in the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after buying an additional 48,674 shares during the period. Trinity Financial Advisors LLC lifted its stake in SeaStar Medical by 233.3% during the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after purchasing an additional 35,000 shares during the last quarter. Finally, Millennium Management LLC bought a new stake in SeaStar Medical during the third quarter worth approximately $102,000. Institutional investors and hedge funds own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.